CBLL · Ceribell, Inc. · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-02 | Woo Raymond |
Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
4,887 |
| 2026-11-02 | Woo Raymond |
Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
23 |
| 2026-11-02 | Woo Raymond |
Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
4,864 |
| 2026-11-02 | Woo Raymond |
Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
23 |
| 2026-11-02 | Woo Raymond |
Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
4,864 |
| 2026-10-01 | Woo Raymond |
Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
4,887 |
| 2026-10-01 | Woo Raymond |
Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
4,864 |
| 2026-10-01 | Woo Raymond |
Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
23 |
| 2026-10-01 | Woo Raymond |
Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
4,864 |
| 2026-10-01 | Woo Raymond |
Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
23 |
| 2026-09-15 | Blumberg Scott |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
Common Stock
|
846 |
| 2026-09-15 | Chao Xingjuan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
Common Stock
|
20,846 |
| 2026-09-15 | Blumberg Scott |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
846 |
| 2026-09-15 | Blumberg Scott |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
Common Stock
|
846 |
| 2026-09-08 | Woo Raymond |
Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
23 |
| 2026-09-08 | Foehr David |
Senior VP, Finance and PAO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.87 to $24.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
Common Stock
|
7,500 |
| 2026-09-08 | Woo Raymond |
Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
8,389 |
| 2026-09-08 | Foehr David |
Senior VP, Finance and PAO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2026. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
7,500 |
| 2026-09-08 | Woo Raymond |
Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of June 10, 2021, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
4,864 |
| 2026-09-08 | Foehr David |
Senior VP, Finance and PAO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.87 to $24.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
Common Stock
|
1,755 |
| 2026-09-08 | Woo Raymond |
Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
4,887 |
| 2026-09-08 | Woo Raymond |
Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
8,389 |
| 2026-09-08 | Woo Raymond |
Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
23 |
| 2026-09-08 | Woo Raymond |
Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. |
Common Stock
|
4,864 |
| 2026-09-08 | Foehr David |
Senior VP, Finance and PAO |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2026. |
Common Stock
|
7,500 |
| 2026-09-02 | Chao Xingjuan |
Director, President and CEO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
23,554 |
| 2026-09-02 | Blumberg Scott |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
Common Stock
|
652 |
| 2026-09-02 | Chao Xingjuan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.24 to $25.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
Common Stock
|
39,540 |
| 2026-09-02 | Chao Xingjuan |
Director, President and CEO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
1,446 |
| 2026-09-02 | Chao Xingjuan |
Director, President and CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. |
Common Stock
|
23,554 |
| 2026-09-02 | Chao Xingjuan |
Director, President and CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. |
Common Stock
|
1,446 |
| 2026-09-02 | Blumberg Scott |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
652 |
| 2026-09-02 | Blumberg Scott |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
Common Stock
|
652 |
| 2026-08-24 | Foehr David |
Senior VP, Finance and PAO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
Common Stock
|
859 |
| 2026-08-21 | Chao Xingjuan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). |
Common Stock
|
6,068 |
| 2026-08-21 | Manni Joseph S. |
Chief Revenue Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Includes 1,026 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026. |
Common Stock
|
1,361 |
| 2026-08-21 | Blumberg Scott |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). |
Common Stock
|
1,521 |
| 2026-08-21 | Woo Raymond |
Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Includes 1,026 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026. |
Common Stock
|
1,979 |
| 2026-08-21 | Foehr David |
Senior VP, Finance and PAO |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). |
Common Stock
|
993 |
| 2026-08-19 | Blumberg Scott |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
Common Stock
|
27,333 |
| 2026-08-19 | Blumberg Scott |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
Common Stock
|
6,179 |
| 2026-08-19 | Blumberg Scott |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
Common Stock
|
33,512 |
| 2026-08-19 | Chao Xingjuan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
Common Stock
|
31,415 |
| 2026-08-19 | Blumberg Scott |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. The stock option is fully vested and currently exercisable. |
Stock Option (Right to Buy)
|
27,333 |
| 2026-08-19 | Blumberg Scott |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
6,179 |
| 2026-08-18 | Blumberg Scott |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026. |
Common Stock
|
690 |
| 2026-08-18 | Blumberg Scott |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
Common Stock
|
300 |
| 2026-08-18 | Blumberg Scott |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
Common Stock
|
990 |
| 2026-08-18 | Blumberg Scott |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
Stock Option (Right to Buy)
|
690 |
| 2026-08-18 | Chao Xingjuan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
Common Stock
|
2,199 |